hydralazine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semenova, NA | 1 |
| Kozin, SV | 2 |
| Kozina, LV | 2 |
| Zaĭtsev, AV | 1 |
| Rozantseva, TV | 1 |
2 other studies available for hydralazine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
[In vivo 31P-NMR spectroscopic study of changes in phosphate metabolism in Ehrlich carcinoma after treatment with hydralazine and hyperthermia].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Hydralazine; Hy | 1996 |
Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Combined Modality Therapy; Hydralazine; Hypertherm | 1999 |